Partnering with the European Union and Global Regulators on COVID-19 | FDA

Partnering with the European Union and Global Regulators on COVID-19 | FDA

Partnering with the European Union and Global Regulators on COVID-19

The European Union (EU) is one of the U.S. Food and Drug Administration’s most important collaborators in tackling public heath challenges. The FDA and the European Commission (EC) and its European Medicines Agency (EMA) have long leveraged each other’s expertise and experience to promote the safety, effectiveness, and quality of medical products to advance the health of our citizens. Now, our work, built together over more than a decade, has paved the way for a multitude of critical collaborations on many scientific and regulatory fronts as part of our COVID-19 response.